Literature DB >> 21606643

The role of high-mobility group box-1 protein in the development of diabetic nephropathy.

Junghyun Kim1, Eunjin Sohn, Chan-Sik Kim, Kyuhyung Jo, Jin Sook Kim.   

Abstract

BACKGROUND/AIMS: The purpose of the experiment reported here was to assess the involvement of high-mobility group box-1 (HMGB1), receptor for advanced glycation end products (RAGE) and nuclear factor (NF)-κB signaling pathway in the development of rat diabetic nephropathy.
METHODS: Diabetes was induced by intraperitoneal streptozotocin injection in 7-week-old male rats. At 20 weeks of age, renal expression of HMGB1 was detected by immunohistochemistry. The expression of RAGE and NF-κB activity was studied by Western blot and electrophoretic mobility shift assay in renal tissues of normoglycemic and diabetic rats, respectively.
RESULTS: HMGB1 was highly expressed in both the cytoplasmic and nuclear patterns in diabetic renal glomerular cells and tubular epithelial cells, although in normal rats, HMGB1 was expressed only in the cell nuclei. The expression of RAGE, a potential receptor for HMGB1, and NF-κB activity were also greater in diabetic than in normal rats. Moreover, diabetes increased the binding of NF-κB to the RAGE promoter.
CONCLUSION: These findings suggest that hyperglycemia-induced HMGB1 release may induce the renal injury in diabetic rats, and that the pathogenic role of HMGB1 might be dependent on RAGE and through activation of NF-κB.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21606643     DOI: 10.1159/000327992

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  25 in total

Review 1.  Unlocking the biology of RAGE in diabetic microvascular complications.

Authors:  Michaele B Manigrasso; Judyta Juranek; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Trends Endocrinol Metab       Date:  2013-09-03       Impact factor: 12.015

2.  Upregulated inflammatory associated factors and blood-retinal barrier changes in the retina of type 2 diabetes mellitus model.

Authors:  Rui-Jin Ran; Xiao-Ying Zheng; Li-Ping Du; Xue-Dong Zhang; Xiao-Li Chen; Shen-Yin Zhu
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 3.  The function and mechanism of HMGB1 in lung cancer and its potential therapeutic implications.

Authors:  Lei Wu; Lili Yang
Journal:  Oncol Lett       Date:  2018-03-08       Impact factor: 2.967

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

5.  HMGB1 is activated in type 2 diabetes mellitus patients and in mesangial cells in response to high glucose.

Authors:  Yan Chen; Fengli Qiao; Ying Zhao; Yanjun Wang; Guifeng Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 6.  The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

Authors:  Marcel H A Muskiet; Mark M Smits; Linde M Morsink; Michaela Diamant
Journal:  Nat Rev Nephrol       Date:  2013-12-24       Impact factor: 28.314

7.  Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations.

Authors:  Deena A Abdulahad; Johanna Westra; Johannes Bijzet; Sebastian Dolff; Marcory C van Dijk; Pieter C Limburg; Cees G M Kallenberg; Marc Bijl
Journal:  Arthritis Res Ther       Date:  2012-08-14       Impact factor: 5.156

8.  Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.

Authors:  Miroslaw J Szczepanski; Michal Luczak; Ewa Olszewska; Marta Molinska-Glura; Mariola Zagor; Antoni Krzeski; Henryk Skarzynski; Jan Misiak; Karolina Dzaman; Mikolaj Bilusiak; Tomasz Kopec; Malgorzata Leszczynska; Henryk Witmanowski; Theresa L Whiteside
Journal:  J Mol Med (Berl)       Date:  2014-11-12       Impact factor: 4.599

9.  Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage.

Authors:  Min Ju Kim; Yunsook Lim
Journal:  Mediators Inflamm       Date:  2013-04-29       Impact factor: 4.711

10.  Extract of Polygonum cuspidatum Attenuates Diabetic Retinopathy by Inhibiting the High-Mobility Group Box-1 (HMGB1) Signaling Pathway in Streptozotocin-Induced Diabetic Rats.

Authors:  Eunjin Sohn; Junghyun Kim; Chan-Sik Kim; Yun Mi Lee; Jin Sook Kim
Journal:  Nutrients       Date:  2016-03-03       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.